372 related articles for article (PubMed ID: 27002129)
21. Virulence genes, Shiga toxin subtypes, major O-serogroups, and phylogenetic background of Shiga toxin-producing Escherichia coli strains isolated from cattle in Iran.
Jajarmi M; Imani Fooladi AA; Badouei MA; Ahmadi A
Microb Pathog; 2017 Aug; 109():274-279. PubMed ID: 28578089
[TBL] [Abstract][Full Text] [Related]
22. Different roles of the C-terminal end of Stx1A and Stx2A for AB5 complex integrity and retrograde transport of Stx in HeLa cells.
Kymre L; Simm R; Skotland T; Sandvig K
Pathog Dis; 2015 Dec; 73(9):ftv083. PubMed ID: 26443836
[TBL] [Abstract][Full Text] [Related]
23. Shiga Toxin Subtypes of Non-O157
Shridhar PB; Siepker C; Noll LW; Shi X; Nagaraja TG; Bai J
Front Cell Infect Microbiol; 2017; 7():121. PubMed ID: 28443248
[TBL] [Abstract][Full Text] [Related]
24. Shiga Toxin (Stx) Type 1a Reduces the Oral Toxicity of Stx Type 2a.
Russo LM; Melton-Celsa AR; O'Brien AD
J Infect Dis; 2016 Apr; 213(8):1271-9. PubMed ID: 26743841
[TBL] [Abstract][Full Text] [Related]
25. Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7.
Fraser ME; Fujinaga M; Cherney MM; Melton-Celsa AR; Twiddy EM; O'Brien AD; James MN
J Biol Chem; 2004 Jun; 279(26):27511-7. PubMed ID: 15075327
[TBL] [Abstract][Full Text] [Related]
26. Entry and killing of Tetrahymena thermophila by bacterially produced Shiga toxin.
Stolfa G; Koudelka GB
mBio; 2012 Dec; 4(1):e00416-12. PubMed ID: 23269826
[TBL] [Abstract][Full Text] [Related]
27. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
[TBL] [Abstract][Full Text] [Related]
28. AB
Biernbaum EN; Kudva IT
Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051039
[TBL] [Abstract][Full Text] [Related]
29. Induction of Shiga Toxin-Encoding Prophage by Abiotic Environmental Stress in Food.
Fang Y; Mercer RG; McMullen LM; Gänzle MG
Appl Environ Microbiol; 2017 Oct; 83(19):. PubMed ID: 28778890
[TBL] [Abstract][Full Text] [Related]
30. A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.
Tremblay JM; Mukherjee J; Leysath CE; Debatis M; Ofori K; Baldwin K; Boucher C; Peters R; Beamer G; Sheoran A; Bedenice D; Tzipori S; Shoemaker CB
Infect Immun; 2013 Dec; 81(12):4592-603. PubMed ID: 24082082
[TBL] [Abstract][Full Text] [Related]
31. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.
Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD
Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486
[TBL] [Abstract][Full Text] [Related]
32. Activatable Shiga toxin 2d (Stx2d) in STEC strains isolated from cattle and sheep at slaughter.
Tasara T; Bielaszewska M; Nitzsche S; Karch H; Zweifel C; Stephan R
Vet Microbiol; 2008 Sep; 131(1-2):199-204. PubMed ID: 18417300
[TBL] [Abstract][Full Text] [Related]
33. Shiga toxin subtypes associated with Shiga toxin-producing Escherichia coli strains isolated from red deer, roe deer, chamois, and ibex.
Hofer E; Cernela N; Stephan R
Foodborne Pathog Dis; 2012 Sep; 9(9):792-5. PubMed ID: 22891940
[TBL] [Abstract][Full Text] [Related]
34. Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity.
Detzner J; Krojnewski E; Pohlentz G; Steil D; Humpf HU; Mellmann A; Karch H; Müthing J
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33673393
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.
Sheoran AS; Dmitriev IP; Kashentseva EA; Cohen O; Mukherjee J; Debatis M; Shearer J; Tremblay JM; Beamer G; Curiel DT; Shoemaker CB; Tzipori S
Infect Immun; 2015 Jan; 83(1):286-91. PubMed ID: 25368111
[TBL] [Abstract][Full Text] [Related]
36. Identification of human-pathogenic strains of Shiga toxin-producing Escherichia coli from food by a combination of serotyping and molecular typing of Shiga toxin genes.
Beutin L; Miko A; Krause G; Pries K; Haby S; Steege K; Albrecht N
Appl Environ Microbiol; 2007 Aug; 73(15):4769-75. PubMed ID: 17557838
[TBL] [Abstract][Full Text] [Related]
37. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.
Brigotti M; He X; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Tazzari PL; Ricci F; Patfield SA; Testa S; Paglialonga F; Picicco D; Caprioli A; Scavia G; Morabito S; Ardissino G
Thromb Haemost; 2020 Jan; 120(1):107-120. PubMed ID: 31858520
[TBL] [Abstract][Full Text] [Related]
38. Gb3-Coated Bovine Milk Exosomes as a Practical Neutralizer for Shiga Toxin.
Lu M; Zhu Y; Li D; Zhou Z; Lin H; Hong H; Shi J; Wu Z
ACS Appl Bio Mater; 2023 Dec; 6(12):5798-5808. PubMed ID: 37988327
[TBL] [Abstract][Full Text] [Related]
39. Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.
Bentancor LV; Mejías MP; Pinto A; Bilen MF; Meiss R; Rodriguez-Galán MC; Baez N; Pedrotti LP; Goldstein J; Ghiringhelli PD; Palermo MS
mBio; 2013 Oct; 4(5):e00501-13. PubMed ID: 24085779
[TBL] [Abstract][Full Text] [Related]
40. The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops.
Creydt VP; Miyakawa MF; Martín F; Zotta E; Silberstein C; Ibarra C
Braz J Med Biol Res; 2004 Jun; 37(6):799-808. PubMed ID: 15264022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
